尖酸一点
发表于 2025-3-23 11:12:21
http://reply.papertrans.cn/63/6225/622427/622427_11.png
驾驶
发表于 2025-3-23 15:56:41
Imaging Modalities for Pheochromocytoma and Paraganglioma,gin. These tumors behave differently from those associated with the parasympathetic system (i.e., head and neck paragangliomas). This chapter will particularly emphasize current and emerging knowledge of imaging options in these tumors.
macrophage
发表于 2025-3-23 19:54:54
http://reply.papertrans.cn/63/6225/622427/622427_13.png
拘留
发表于 2025-3-24 00:22:52
Cushing Syndrome: Presentation, Diagnosis, and Treatment, Including Subclinical Cushing Syndrome,ectrum of this heterogeneous disorder can range broadly from subclinical or mild variants to severe florid forms..Biochemical screening for CS is recommended in patients with multiple and progressive features compatible with the syndrome, and patients with adrenal incidentaloma. Using one of the fir
我悲伤
发表于 2025-3-24 03:52:11
Management of Pheochromocytoma and Paraganglioma, in 12-well identified genes. Patients present with a wide range of clinical manifestations including paroxysms of hypertension, headaches, palpitations, and sweating, being the most common. The high levels of circulating catecholamines predispose patients to catastrophic cardiovascular complication
裂口
发表于 2025-3-24 08:31:27
http://reply.papertrans.cn/63/6225/622427/622427_16.png
Interregnum
发表于 2025-3-24 12:04:23
http://reply.papertrans.cn/63/6225/622427/622427_17.png
Femish
发表于 2025-3-24 17:34:33
http://reply.papertrans.cn/63/6225/622427/622427_18.png
GLIB
发表于 2025-3-24 22:11:30
Therapies for Locally Advanced and Metastatic Adrenocortical Carcinoma,ns challenging because of the lack of effective systemic chemotherapy options. Patients with hormonally active ACC have added morbidity associated with hormonal excess syndromes, which further complicates therapy. Surgery is often not feasible in these patients, and systemic therapy is often favored
lipoatrophy
发表于 2025-3-24 23:35:42
Management of Locally Advanced and Metastatic Pheochromocytoma and Paraganglioma,ion and there are no clear pathological factors predictive of metastasis. However, a primary tumor size larger than 5 cm, succinate dehydrogenase B (.) mutations, or extra-adrenal location are clinical predictors of metastatic disease. Patients with these factors at the initial presentation should h